Breast Protocol - ADJUVANT - NRG-BR003

NRG-BR003

A Randomized Phase III Trial of Adjuvant Therapy Comparing Doxoubicin Plus Cyclophosphamide Followed by Weekly Paclitaxel with or without Carboplatin for Node-Positive or High-Risk Node Negative Invasive Breast Cancer.